ANDROGEN RECEPTORS AND WNT PATHWAY AS THERAPEUTIC TARGETS IN ENDOCRINE RESISTANT BREAST CANCER MODELS
Elucidating the role of FGFR2 activation and RUNX2 expression in the progression of luminal breast cancer
Invasive mammary carcinomas with different progesterone receptor isoform ratios: metastatic vs. proliferative ability, which is worse?
Combination of GnRH Agonist/Antagonist with Protein Kinase Inhibitors Counteracts Growth and Metastasis in Breast Cancer
Seeking the Truth Behind the Myth: Nuclear Role for Argonaute-1 as an Estrogen-Dependent Enhancer Coactivator